| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026 |
MBX Biosciences, Inc. Common Stock
MBX
|
BUY |
$88.00
Est. +115%
|
$40.91 | $45.61 |
Pending
|
$43.03
+5.2%
|
| Dec 17, 2025 |
Rhythm Pharmaceuticals Inc.
RYTM
|
BUY |
$140.00
Est. +24%
|
$112.45 | $115.05 |
Pending
|
$96.79
-13.9%
|
| Sep 24, 2025 |
Cidara Therapeutics Inc
CDTX
|
BUY |
$167.00
Est. +93%
|
$86.68 | $221.42 |
Target Met
|
$221.38
+155.4%
|
| Sep 15, 2025 |
Amylyx Pharmaceuticals Inc
AMLX
|
BUY |
$25.00
Est. +111%
|
$11.85 | $18.61 |
Pending
|
$15.67
+32.2%
|
| Jul 09, 2025 |
Cidara Therapeutics Inc
CDTX
|
BUY |
$69.00
Est. +35%
|
$50.96 | $221.42 |
Target Met
|
$221.38
+334.4%
|
| Jun 24, 2025 |
Amylyx Pharmaceuticals Inc
AMLX
|
BUY |
$17.00
Est. +165%
|
$6.41 | $18.61 |
Target Met
|
$15.67
+144.5%
|
| May 16, 2025 |
Cidara Therapeutics Inc
CDTX
|
BUY |
$50.00
Est. +96%
|
$25.50 | $221.42 |
Target Met
|
$221.38
+768.2%
|
| May 15, 2025 |
Tenax Therapeutics Inc
TENX
|
BUY |
$15.00
Est. +163%
|
$5.70 | $18.38 |
Target Met
|
$12.00
+110.5%
|
| May 14, 2025 |
Mineralys Therapeutics Inc
MLYS
|
BUY |
$48.00
Est. +218%
|
$15.11 | $47.65 |
Bullseye Hit (±1%)
|
$24.63
+63.0%
|
| Oct 08, 2024 |
MBX Biosciences, Inc. Common Stock
MBX
|
BUY |
$44.00
Est. +82%
|
$24.20 | $26.45 |
Miss
|
$43.03
+77.8%
|
| May 02, 2022 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$80.00
Est. +6%
|
$75.27 | - | - |
$54.00
-28.3%
|
| Sep 21, 2021 |
Lilly(Eli) & Co
LLY
|
BUY |
$266.00
Est. +16%
|
$228.47 | - | - |
$1,098.13
+380.6%
|
| Sep 20, 2021 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$82.00
Est. +39%
|
$59.05 | - | - |
$54.00
-8.6%
|